BioByte 068: Cell therapy for solid tumors, using a monoclonal for allergy, improving AlphaFold2 performance, using ML to understand small RNA secretion, Insilico's development of a TNIK inhibitor
BioByte 068: Cell therapy for solid tumors, using a monoclonal for allergy, improving AlphaFold2 performance, using ML to understand small RNA secretion, Insilico's development of a TNIK inhibitor
www.decodingbio.com
Welcome to Decoding Bio, a writing collective focused on the latest scientific advancements, news, and people building at the intersection of tech x bio. Happy decoding! Welcome to Spring. If there’s one thing we’ve learned, it’s that seasons are ephemeral, but Decoding is forever. Almost like that Hotel California line: “You can check out any time you like, but you can never leave!”
BioByte 068: Cell therapy for solid tumors, using a monoclonal for allergy, improving AlphaFold2 performance, using ML to understand small RNA secretion, Insilico's development of a TNIK inhibitor
BioByte 068: Cell therapy for solid tumors…
BioByte 068: Cell therapy for solid tumors, using a monoclonal for allergy, improving AlphaFold2 performance, using ML to understand small RNA secretion, Insilico's development of a TNIK inhibitor
Welcome to Decoding Bio, a writing collective focused on the latest scientific advancements, news, and people building at the intersection of tech x bio. Happy decoding! Welcome to Spring. If there’s one thing we’ve learned, it’s that seasons are ephemeral, but Decoding is forever. Almost like that Hotel California line: “You can check out any time you like, but you can never leave!”